Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 27 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 24 25 26 27 presentations: 1 to 25 of 660
Immune modulation by stroma in solid tumors
Ellen Pure
Univ. of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Innate immune signaling in cancer: New concepts
Glen N. Barber
University of Miami, Miami, FL, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Tumor-derived exosomes suppress functions of immune cells and may interfere with immune therapies
Theresa L. Whiteside
Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Overcoming immune checkpoints to treat cancer
Charles G. Drake
Columbia Univ. Medical Ctr., New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Somatic HLA mutations and neoantigen identification for immunotherapy analyses
Sachet A Shukla
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Dynamics of genomic and neoantigen landscape during immune checkpoint blockade
Valsamo Anagnostou
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Integrative clinical and genomic analysis of solid tumors treated with immune checkpoint blockade
Jeffrey E Hammerbacher
Icahn School Of Medicine At Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Infiltrating immune cell signatures and genomic determinants of immune recognition in diverse tumors
Ash A. Alizadeh
Stanford Univ., Stanford, CA, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Panel Discussion
Laleh Amiri-Kordestani
FDA, Silver Spring, MD, United States
Javid M. Moslehi
Vanderbilt Univ. School of Medicine, Nashville, TN, United States
George D. Demetri
Dana-Farber Cancer Inst. and Harvard Med, Boston, MA, United States
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Introduction
Cornelia Liu Trimble
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
High-dimensional immune monitoring of tumor tissues for cancer immunotherapy
Sacha Gnjatic
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Targeting pathogen-induced malignancies: Lessons learned from adoptive T cell transfer for merkel cell carcinoma
Aude G. Chapuis
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Developing a biomarker platform to serve targeted therapy and immunotherapy
Keith T Flaherty
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
High-dimensional analyses of the mucosal microenvironment in precancerous, intraepithelial cervical HPV disease
Cornelia L. Trimble
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 3:15 PM-5:15 PM
Invited Speaker
Weiping Zou
Univ. of Michigan, Ann Arbor, MI, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Jeffrey S. Miller
Univ. of Minnesota, Minneapolis, MN, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Invited Speaker
Daniel S. Chen
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
OX40 agonists: Past, present, and future
Andrew D Weinberg
Robert W. Franz Cancer Research Center, Portland, OR, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Preclinical assessment of JTX-2011, an agonist antibody targeting ICOS, supports evaluation in ICONIC clinical trial
Jennifer S. Michaelson
Jounce Therapeutics, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Isotype choice for antibody immunotherapy: Lessons from engineering anti-CD73 and anti-TIGIT therapeutic antibodies
Bryan C. Barnhart
Bristol-Myers Squibb Co., Redwood City, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Chair
Robert J. Gillies
Moffitt Cancer Center & Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Tumor immune-pathology from the molecular scale on up
Garry P. Nolan
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
<< first | < prev page: of 27 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 24 25 26 27 presentations: 1 to 25 of 660